Keywords: Tumors (Pre-Treatment), Brain
Motivation: Promoter methylation of MGMT in glioblastoma is associated with beneficial treatment outcomes and prognosis; however, MGMT testing is costly, and molecular detection is not available in some hospitals.
Goal(s): This study aims to construct a model based on MRI and pathological images to predict the status of MGMT.
Approach: MRI and pathological images from patients with glioblastoma and a machine learning model was established to predict the MGMT status.
Results: The combination of MRI and pathological images demonstrated superior predictive performance for MGMT compared to either MRI or pathological images alone.
Impact: This research provides a method for therapeutic decision-making and prognostic prediction in glioblastoma, offering a potential approach for the future integration of multi-information for accurate prediction and clinical application in other tumors.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords